For research use only. Not for therapeutic Use.
Ipflufenoquin (Cat No.: I040186) is a synthetic anti-inflammatory compound primarily used in the treatment of eye conditions, particularly for its ability to reduce inflammation and oxidative stress. It is a potent inhibitor of lipid peroxidation and works by targeting the cyclooxygenase (COX) pathway. Ipflufenoquin has been studied for its potential in treating retinal diseases, such as diabetic retinopathy and age-related macular degeneration, by promoting vascular health and reducing oxidative damage. Its use in ophthalmology continues to be explored in clinical settings.
| CAS Number | 1314008-27-9 |
| Synonyms | 2-[2-(7,8-difluoro-2-methylquinolin-3-yl)oxy-6-fluorophenyl]propan-2-ol |
| Molecular Formula | C19H16F3NO2 |
| Purity | ≥95% |
| IUPAC Name | 2-[2-(7,8-difluoro-2-methylquinolin-3-yl)oxy-6-fluorophenyl]propan-2-ol |
| InChI | InChI=1S/C19H16F3NO2/c1-10-15(9-11-7-8-13(21)17(22)18(11)23-10)25-14-6-4-5-12(20)16(14)19(2,3)24/h4-9,24H,1-3H3 |
| InChIKey | DSXOWZNZGWXWMX-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C2C=CC(=C(C2=N1)F)F)OC3=C(C(=CC=C3)F)C(C)(C)O |
| Reference | [1]. Hirayama K. Curative effects of fungicides against Venturia inaequalis causing apple scab[J]. Journal of General Plant Pathology, 2022, 88(4): 264-269. |
